Rosiglitazone HCl

Rosiglitazone HCl is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.

302543-62-0

≥ 2 years

>98% (HPLC)

393.89

C18H19N3O3S·HCl

Research use only, not for human use.

PPAR

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

L1050-61K-ML650 100 µL

Ask

E-AB-14886-01 20 µL

Ask

E-AB-14886-02 60 μL

Ask

E-AB-14886-03 120 μL

Ask

E-AB-14886-04 200 µL

Ask

48832031 100 µg

Ask